DrugsControl Media Services

News Detail

Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints (14-02-2023)

Boston, 13 Feb 2023: About 10% of drugs approved by the US Food and Drug Administration (FDA) between 2018 and 2021 had pivotal trials with null findings, according to a research letter published in JAMA Internal Medicine.
“Our findings underscore ......
View Details

Source : Regulatory News
drugs approved US Food and Drug Administration pivotal trials with null findings JAMA Internal Medicine new drug applications

Related News